✦ LIBER ✦

PDB13 BUDGET IMPACT ANALYSIS OF SAXAGLIPTIN FOR THE TREATMENT OF DIABETES MELLITUS TYPE 2 (T2D) PATIENTS IN THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM

✍ Scribed by E Barbosa; E Ribeiro; E Asano; M Nita; R Rached; P Mantilla; A Pimentel; BM Donato; E Rahal

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness and budget impact of

✍ Nita, Marcelo Eidi; Eliaschewitz, Freddy G.; Ribeiro, Eliane; Asano, Elio; Barbo 📂 Article 📅 2012 🏛 Elsevier ⚖ 107 KB

PDB14 BUDGET IMPACT ANALYSIS OF THE INTR

✍ J Elgart; J Caporale; JJ Gagliardino; M Waschbusch; EC Aiello; L Jotimliansky 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PDB20 BUDGET IMPACT ANALYSIS OF THE INTR

✍ J. Elgart; J. Caporale; E.C. Aiello; J.J. Gagliardino; M. Waschbusch; L. Jotimli 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

PDB19 BUDGET IMPACT ANALYSIS OF SAXAGLIP

✍ A Juarez-Garcia; G Martinez-Rivera; P Anaya; BM Donato 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

PDB13 DIAPS 79, PRELIMINARY REPORT OF AN

✍ L Bahia; FG Eliaschewitz; L Franco; CY Hayashida; BD Schaan; A Forti; M Cintra; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PDB62 COST-UTILITY ANALYSIS OF SAXAGLIPT

✍ FG Eliaschewitz; E Asano; ME Nita; R Rached; BM Donato 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB